Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shexiang Tongxin Dropping Pills for coronary slow flow
ChiCTR2000035167Phase 4Recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Shexiang Tongxin Dropping Pills in Slow Coronary Flow (SCF) (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoints: corrected TIMI frame count, cardiac radionuclide score and 17 more. Started Sep 2020; status: recruiting.
02
Drugs
Shexiang Tongxin Dropping Pills
03
Conditions
Slow Coronary Flow (SCF)
Beyond the preview
Go deeper on ChiCTR2000035167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035167.